Yuval Cohen
Chief Executive Officer at CORBUS PHARMACEUTICALS HOLDINGS, INC.
Net worth: 3 M $ as of 2024-05-30
Yuval Cohen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2014-04-10 | - |
| Chief Executive Officer | 2014-04-10 | - | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Director/Board Member | 2013-06-30 | - |
| Chief Executive Officer | 2013-06-30 | - |
Career history of Yuval Cohen
Former positions of Yuval Cohen
| Companies | Position | Start | End |
|---|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Director/Board Member | 2004-12-31 | 2013-01-31 |
| Founder | 2004-12-31 | 2013-11-30 | |
| Corporate Officer/Principal | 2013-01-31 | 2013-11-30 | |
| President | 2004-12-31 | 2013-01-31 |
Training of Yuval Cohen
| University of Cape Town | Undergraduate Degree |
Statistics
International
| United States | 3 |
| United Kingdom | 2 |
| South Africa | 2 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
- Stock Market
- Insiders
- Yuval Cohen
- Experience
